Latest Endo Health Solutions Stories
NDA filing for BEMA Buprenorphine/Naloxone (BUNAVAIL) on track for mid-2013 RALEIGH, N.C., March 18, 2013 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that it has filed its Annual Report on Form 10-K for the year ended December 31, 2012 with the U.S. Securities and Exchange Commission and, in connection therewith, is providing a review of BDSI's 2012 achievements and an update on business operations and upcoming milestones for 2013. (Logo:...
HUNTSVILLE, Ala., Dec. 6, 2012 /PRNewswire/ -- Qualitest, a subsidiary of Endo Health Solutions, (Nasdaq: ENDP) today issued a voluntary nationwide recall for 101 lots of Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/500 mg. This includes product with the following NDC numbers and lot numbers beginning with the letter "C". NDC Number Bottle Count ---------- ------------ 0603-3888-16 30...
RALEIGH, N.C., Nov. 8, 2012 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that it has filed its Quarterly Report on Form 10-Q for the quarter ended September 30, 2012, with the U.S. Securities and Exchange Commission and, in connection therewith, is providing a review of the Company's recent achievements and upcoming milestones. (Logo: http://photos.prnewswire.com/prnh/20110217/CL49801LOGO ) "This has been a year of remarkable progress,...
CHADDS FORD, Pa., Nov. 8, 2012 /PRNewswire/ -- Endo Health Solutions (Nasdaq: ENDP) today announced that Julie McHugh, chief operating officer, will present a corporate overview at the 2012 Annual Credit Suisse Healthcare Conference on Thursday, Nov. 15, 2012, at 1:00 p.m. MST (3:00 p.m. ET). The conference will be held at the Arizona Biltmore in Phoenix. A live webcast and audio archive of the presentation will be available on the company's website at http://www.endo.com/. Click...
CHADDS FORD, Pa., Nov. 7, 2012 /PRNewswire/ -- Endo Health Solutions (Nasdaq: ENDP) today announced that Alan Levin, chief financial officer, will present a corporate overview at the Jefferies 2012 Global Healthcare Conference on Wednesday, Nov. 14, 2012, at 8:00 a.m. GMT (3:00 a.m. ET). The conference will be held at the Waldorf Hilton in London. A live webcast and audio archive of the presentation will be available on the company's website at http://www.endo.com/. Click on...
CHADDS FORD, Pa., Oct. 4, 2012 /PRNewswire-FirstCall/ -- Highlights long-term growth drivers and investment attributes of the company Endo updates 2012 performance, reaffirms full year 2012 revenues of $3.05 to $3.175 billion and adjusted diluted EPS in the range of $5.00 to $5.20; expects reported or GAAP diluted EPS of $1.37 to $1.57 Company expects 2013 revenue of $3.0 to $3.2 billion and adjusted diluted EPS of $5.20 to $5.40; expects reported or GAAP diluted EPS of $3.17 to...
CHADDS FORD, Pa., Sept. 28, 2012 /PRNewswire/ -- Endo Health Solutions (Nasdaq: ENDP) today announced that it will host an Investor Meeting on Oct. 4, 2012, in New York City. The company will provide a live audio and slide webcast of this Investor Meeting beginning at 9:00 a.m. ET on Oct. 4, 2012. The meeting is expected to conclude by 12:30 p.m. ET. David P. Holveck, president and CEO of Endo, Julie McHugh, chief operating officer, Dr. Ivan Gergel, executive vice president of...
CHADDS FORD, Pa., Sept. 5, 2012 /PRNewswire/ -- Endo Health Solutions (Nasdaq: ENDP) today announced that Julie McHugh, chief operating officer, will present a corporate overview at the UBS 2012 Global Life Sciences Conference on Wednesday, Sept. 19, 2012, at 2:00 p.m. ET. The conference will be held at the Grand Hyatt in New York City. A live webcast and audio archive of the presentation will be available on the company's website at http://www.endo.com/. Click on Investor...
CHADDS FORD, Pa., Aug. 23, 2012 /PRNewswire/ -- Endo Health Solutions (Nasdaq: ENDP) today issued the following statement regarding the U.S. Food and Drug Administration's (FDA) response to Endo's Citizen Petition (CP) related to the approval requirements for generic versions of LIDODERM (lidocaine patch 5%), a locally-acting topical medication for the relief of pain associated with post-herpetic neuralgia. "We are disappointed in FDA's decision to deny the citizen petition and...
CHADDS FORD, Pa., Aug. 21, 2012 /PRNewswire/ -- Endo Health Solutions (Nasdaq: ENDP) today announced that Blaine Davis, senior vice president corporate affairs, will present a corporate overview at the Stifel Nicolaus 2012 Healthcare Conference on Wednesday, September 5, 2012 at 8:35 a.m. ET. The conference will be held at the Four Seasons in Boston, Massachusetts. A live webcast and audio archive of the presentation will be available on the company's website at...
